A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)

Clinical trial NCT00443391 · COMPLETED

Trial details

NCT number: NCT00443391
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2007-02-01
Primary completion: 2008-10-01
Enrollment: 141

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.